The Texas Court of Appeals recently ruled in favor of the University of Texas System and its affiliates, dismissing claims brought by Gensetix, Inc. The court found that Gensetix's allegations of breach of contract and constitutional taking were barred by sovereign immunity. This ruling, issued on June 18, 2026, affects the legal landscape surrounding contracts involving state entities and their obligations.
The case, titled The Board of Regents of the University of Texas System, the University of Texas System, and the University of Texas M.D. Anderson Cancer Center v. Gensetix, Inc., was filed under docket number 15-25-00011-CV. Gensetix alleged that the MD Anderson Cancer Center and the University of Texas System breached a licensing agreement related to cancer treatment technology. The court's decision emphasizes the protections that sovereign immunity provides to state entities in Texas.
The dispute began when Gensetix claimed that it had entered into a "Patent and Technology License Agreement" with MD Anderson, which was part of the University of Texas System. Gensetix argued that it had paid substantial sums and invested in the development of cancer-treating technology, expecting cooperation from MD Anderson in any legal disputes regarding patent infringement. However, when Gensetix sought to sue a third party for patent infringement, MD Anderson refused to participate, citing sovereign immunity. This led Gensetix to file a lawsuit against MD Anderson, alleging breach of contract and a constitutional taking of its property.
The MD Anderson Parties challenged the lawsuit by filing a plea to the jurisdiction, asserting that they were protected from suit by sovereign immunity. The trial court initially denied this plea, prompting the MD Anderson Parties to appeal the decision. The Texas Court of Appeals ultimately reversed the trial court's ruling, stating that Gensetix's claims did not demonstrate a valid waiver of immunity.
In its ruling, the court stated, "Because we conclude that the allegations in Gensetix’s pleadings and the jurisdictional evidence are insufficient to support a claim for which immunity is waived, we reverse the trial court’s judgment and render judgment dismissing the suit for lack of jurisdiction." The judges overseeing the case included Chief Justice Brister and Justices Field and Farris.
The court's decision has significant implications for future cases involving state entities and their contractual obligations. Sovereign immunity generally protects governmental bodies from lawsuits unless there is a clear legislative waiver. In this case, the court found that Gensetix did not provide sufficient evidence to show that its claims fell under an exception to this immunity. The ruling reinforces the principle that simply entering into a contract does not waive a governmental entity's immunity from suit.
Looking ahead, this ruling may affect other businesses and individuals seeking to engage in contracts with state entities in Texas. It highlights the importance of understanding the limitations of legal recourse in disputes involving governmental bodies. As businesses navigate agreements with state institutions, they must be aware of the potential barriers posed by sovereign immunity.
As for the possibility of an appeal, the court's ruling is a final decision on the matter. Gensetix may not have further recourse in this case, as the court has dismissed its claims. Details were not available in the court filing regarding any related cases or future actions by Gensetix.